ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany
· Delayed Price · Currency is EUR 69.50
-1.00 (-1.42%)
At close: Dec 4, 2025
ANI Pharmaceuticals Revenue
ANI Pharmaceuticals had revenue of $227.81M USD in the quarter ending September 30, 2025, with 53.58% growth. This brings the company's revenue in the last twelve months to $826.88M, up 48.87% year-over-year. In the year 2024, ANI Pharmaceuticals had annual revenue of $614.38M with 26.20% growth.
Revenue (ttm)
$826.88M
Revenue Growth
+48.87%
P/S Ratio
2.08
Revenue / Employee
$921.83K
Employees
897
Market Cap
1.47B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 614.38M | 127.56M | 26.20% |
| Dec 31, 2023 | 486.82M | 170.43M | 53.87% |
| Dec 31, 2022 | 316.39M | 100.25M | 46.38% |
| Dec 31, 2021 | 216.14M | 7.66M | 3.67% |
| Dec 31, 2020 | 208.48M | 1.93M | 0.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |